FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36609311000001100: Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112546101000001117 Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112546201000001112 Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Is a Entecavir 500microgram tablets 30 tablet true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has AMP Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has basis of strength substance Entecavir true Inferred relationship Existential restriction modifier 1
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has presentation strength numerator value 500 false Inferred relationship Existential restriction modifier 1
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has presentation strength numerator unit microgram true Inferred relationship Existential restriction modifier 1
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has precise active ingredient Entecavir true Inferred relationship Existential restriction modifier 1
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Entecavir monohydrate true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Entecavir true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start